Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
Neuropharmacology. 2013 Sep;72:82-7. doi: 10.1016/j.neuropharm.2013.04.042. Epub 2013 May 2.
The dopamine (DA) D3 receptor (D3R) has received much attention in medication development for treatment of addiction. However, the functional role of the D3R in drug reward and addiction has been a matter of debate. We recently reported that D3 receptor-knockout (D3(-/-)) mice display increased vulnerability to cocaine self-administration, which we interpret as a compensatory response to attenuated cocaine reward after D3R deletion. Here we report that D3(-/-) mice displayed attenuated cocaine-induced conditioned place response (CPP) compared to wild-type mice. Similarly, blockade of brain D3Rs by YQA-14, a novel DA D3 receptor antagonist, significantly and dose-dependently inhibits acquisition and expression of cocaine-induced CPP in WT mice, but not in D3(-/-) mice. These findings suggest that: 1) D3Rs play an important role in mediating cocaine's rewarding effects; and 2) YQA-14 is a highly potent and selective D3R antagonist in vivo, which deserves further study as a candidate for treatment of cocaine addiction.
多巴胺(DA)D3 受体(D3R)在治疗成瘾的药物开发中受到了广泛关注。然而,D3R 在药物奖赏和成瘾中的功能作用一直存在争议。我们最近报道称,D3 受体敲除(D3(-/-))小鼠对可卡因自我给药表现出更高的易感性,我们将其解释为 D3R 缺失后可卡因奖赏减弱的代偿反应。在这里,我们报告称,与野生型小鼠相比,D3(-/-)小鼠表现出可卡因诱导的条件位置反应(CPP)减弱。同样,新型多巴胺 D3 受体拮抗剂 YQA-14 阻断脑 D3R,可显著且剂量依赖性地抑制 WT 小鼠可卡因诱导 CPP 的获得和表达,但对 D3(-/-)小鼠无作用。这些发现表明:1)D3R 在介导可卡因的奖赏效应中起重要作用;2)YQA-14 是一种在体内具有高度效力和选择性的 D3R 拮抗剂,值得进一步研究作为可卡因成瘾治疗的候选药物。